Carrillo-Mora, P.; Landa-SolÃs, C.; Valle-Garcia, D.; Luna-Angulo, A.; Avilés-Arnaut, H.; Robles-Bañuelos, B.; Sánchez-Chapul, L.; Rangel-López, E.
Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment. Pharmaceuticals 2024, 17, 983.
https://doi.org/10.3390/ph17080983
AMA Style
Carrillo-Mora P, Landa-SolÃs C, Valle-Garcia D, Luna-Angulo A, Avilés-Arnaut H, Robles-Bañuelos B, Sánchez-Chapul L, Rangel-López E.
Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment. Pharmaceuticals. 2024; 17(8):983.
https://doi.org/10.3390/ph17080983
Chicago/Turabian Style
Carrillo-Mora, Paul, Carlos Landa-SolÃs, David Valle-Garcia, Alexandra Luna-Angulo, Hamlet Avilés-Arnaut, BenjamÃn Robles-Bañuelos, Laura Sánchez-Chapul, and Edgar Rangel-López.
2024. "Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment" Pharmaceuticals 17, no. 8: 983.
https://doi.org/10.3390/ph17080983
APA Style
Carrillo-Mora, P., Landa-SolÃs, C., Valle-Garcia, D., Luna-Angulo, A., Avilés-Arnaut, H., Robles-Bañuelos, B., Sánchez-Chapul, L., & Rangel-López, E.
(2024). Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment. Pharmaceuticals, 17(8), 983.
https://doi.org/10.3390/ph17080983
